Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381470212> ?p ?o ?g. }
- W4381470212 endingPage "1382" @default.
- W4381470212 startingPage "1374" @default.
- W4381470212 abstract "Chronic kidney disease (CKD) confers a high risk of thrombosis and bleeding. However, little evidence exists regarding the optimal choice of postoperative thromboprophylaxis in these patients. We conducted a population-based, retrospective cohort study among adults ≥66 years old with CKD undergoing hip or knee arthroplasty who had filled an outpatient prophylactic anticoagulant prescription between 2010 and 2020 in Ontario, Canada. The primary outcomes of venous thrombosis (VTE) and hemorrhage were identified by validated algorithms using relevant diagnoses and billing codes. Overlap-weighted cause-specific Cox proportional hazard models were used to examine the association of direct oral anticoagulants (DOAC) on the 90-day risk of VTE and hemorrhage compared with low-molecular-weight heparin (LMWH). A total of 27 645 patients were prescribed DOAC (N = 22 943) or LMWH (N = 4702) after arthroplasty. Rivaroxaban was the predominant DOAC (94.5%), while LMWH mainly included enoxaparin (67%) and dalteparin (31.5%). DOAC users had higher eGFRs, fewer co-morbidities, and surgery in more recent years compared to LMWH users. After weighing, DOAC (compared with LMWH) was associated with a lower risk of VTE (DOAC: 1.5% vs. LMWH: 2.1%, weighted hazard ratio [HR] 0.75, 95% confidence interval [CI] 0.59-0.94) and a higher risk of hemorrhage (DOAC: 1.3% vs. LMWH: 1.0%, weighted HR 1.44, 95% CI 1.04-1.99). Additional analyses including a more stringent VTE defining algorithm, different eGFR cut-offs, and limiting to rivaroxaban and enoxaparin showed consistent findings. Among elderly adults with CKD, DOAC was associated with a lower VTE risk and a higher hemorrhage risk compared to LMWH following hip or knee arthroplasty." @default.
- W4381470212 created "2023-06-22" @default.
- W4381470212 creator A5001302156 @default.
- W4381470212 creator A5001918058 @default.
- W4381470212 creator A5007940551 @default.
- W4381470212 creator A5019993195 @default.
- W4381470212 creator A5024688180 @default.
- W4381470212 creator A5033748408 @default.
- W4381470212 creator A5040983228 @default.
- W4381470212 creator A5044179329 @default.
- W4381470212 creator A5054511215 @default.
- W4381470212 creator A5063670543 @default.
- W4381470212 creator A5068260242 @default.
- W4381470212 date "2023-06-21" @default.
- W4381470212 modified "2023-09-25" @default.
- W4381470212 title "Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty" @default.
- W4381470212 cites W1572788090 @default.
- W4381470212 cites W1821819993 @default.
- W4381470212 cites W1839975480 @default.
- W4381470212 cites W1973357685 @default.
- W4381470212 cites W1981830415 @default.
- W4381470212 cites W2010599049 @default.
- W4381470212 cites W2037417478 @default.
- W4381470212 cites W2049491523 @default.
- W4381470212 cites W2050412522 @default.
- W4381470212 cites W2061326496 @default.
- W4381470212 cites W2105320272 @default.
- W4381470212 cites W2105948109 @default.
- W4381470212 cites W2149374917 @default.
- W4381470212 cites W2163278718 @default.
- W4381470212 cites W2286779217 @default.
- W4381470212 cites W2622299066 @default.
- W4381470212 cites W2788601536 @default.
- W4381470212 cites W2890318547 @default.
- W4381470212 cites W2991907358 @default.
- W4381470212 cites W3016782834 @default.
- W4381470212 cites W3023814660 @default.
- W4381470212 cites W3033168195 @default.
- W4381470212 cites W3099724350 @default.
- W4381470212 cites W4226390647 @default.
- W4381470212 cites W4292840770 @default.
- W4381470212 doi "https://doi.org/10.1002/ajh.26994" @default.
- W4381470212 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37340812" @default.
- W4381470212 hasPublicationYear "2023" @default.
- W4381470212 type Work @default.
- W4381470212 citedByCount "0" @default.
- W4381470212 crossrefType "journal-article" @default.
- W4381470212 hasAuthorship W4381470212A5001302156 @default.
- W4381470212 hasAuthorship W4381470212A5001918058 @default.
- W4381470212 hasAuthorship W4381470212A5007940551 @default.
- W4381470212 hasAuthorship W4381470212A5019993195 @default.
- W4381470212 hasAuthorship W4381470212A5024688180 @default.
- W4381470212 hasAuthorship W4381470212A5033748408 @default.
- W4381470212 hasAuthorship W4381470212A5040983228 @default.
- W4381470212 hasAuthorship W4381470212A5044179329 @default.
- W4381470212 hasAuthorship W4381470212A5054511215 @default.
- W4381470212 hasAuthorship W4381470212A5063670543 @default.
- W4381470212 hasAuthorship W4381470212A5068260242 @default.
- W4381470212 hasBestOaLocation W43814702121 @default.
- W4381470212 hasConcept C126322002 @default.
- W4381470212 hasConcept C141071460 @default.
- W4381470212 hasConcept C167135981 @default.
- W4381470212 hasConcept C207103383 @default.
- W4381470212 hasConcept C2776301958 @default.
- W4381470212 hasConcept C2776884760 @default.
- W4381470212 hasConcept C2778205648 @default.
- W4381470212 hasConcept C2778336525 @default.
- W4381470212 hasConcept C2778653478 @default.
- W4381470212 hasConcept C2778661090 @default.
- W4381470212 hasConcept C2779161974 @default.
- W4381470212 hasConcept C2780011451 @default.
- W4381470212 hasConcept C2780638905 @default.
- W4381470212 hasConcept C2780868729 @default.
- W4381470212 hasConcept C2908647359 @default.
- W4381470212 hasConcept C44249647 @default.
- W4381470212 hasConcept C71924100 @default.
- W4381470212 hasConcept C99454951 @default.
- W4381470212 hasConceptScore W4381470212C126322002 @default.
- W4381470212 hasConceptScore W4381470212C141071460 @default.
- W4381470212 hasConceptScore W4381470212C167135981 @default.
- W4381470212 hasConceptScore W4381470212C207103383 @default.
- W4381470212 hasConceptScore W4381470212C2776301958 @default.
- W4381470212 hasConceptScore W4381470212C2776884760 @default.
- W4381470212 hasConceptScore W4381470212C2778205648 @default.
- W4381470212 hasConceptScore W4381470212C2778336525 @default.
- W4381470212 hasConceptScore W4381470212C2778653478 @default.
- W4381470212 hasConceptScore W4381470212C2778661090 @default.
- W4381470212 hasConceptScore W4381470212C2779161974 @default.
- W4381470212 hasConceptScore W4381470212C2780011451 @default.
- W4381470212 hasConceptScore W4381470212C2780638905 @default.
- W4381470212 hasConceptScore W4381470212C2780868729 @default.
- W4381470212 hasConceptScore W4381470212C2908647359 @default.
- W4381470212 hasConceptScore W4381470212C44249647 @default.
- W4381470212 hasConceptScore W4381470212C71924100 @default.
- W4381470212 hasConceptScore W4381470212C99454951 @default.
- W4381470212 hasIssue "9" @default.
- W4381470212 hasLocation W43814702121 @default.
- W4381470212 hasLocation W43814702122 @default.